Clinical and genetic aspects of KBG syndrome. by Low, K. et al.
ORIGINAL ARTICLEClinical and Genetic Aspects of KBG Syndrome
Karen Low,1* Tazeen Ashraf,2 Natalie Canham,3 Jill Clayton-Smith,4,5 Charu Deshpande,2
Alan Donaldson,1 Richard Fisher,6 Frances Flinter,2 Nicola Foulds,7 Alan Fryer,8 Kate Gibson,9
Ian Hayes,10 Alison Hills,11 Susan Holder,3 Melita Irving,2 Shelagh Joss,12 Emma Kivuva,13
Kathryn Lachlan,7 Alex Magee,14 Vivienne McConnell,14 Meriel McEntagart,15 Kay Metcalfe,4
Tara Montgomery,16 Ruth Newbury-Ecob,1 Fiona Stewart,14 Peter Turnpenny,13 Julie Vogt,17
David Fitzpatrick,18 Maggie Williams,11 DDD Study,19 and Sarah Smithson1
1University Hospitals Bristol NHS Trust/University of Bristol, Bristol, United Kingdom
2Guy’s and St Thomas’ NHS Trust, London, United Kingdom
3North West Thames Regional Genetics Service, Harrow, London, United Kingdom
4Manchester Centre For Genomic Medicine, St Mary’s Hospital Manchester, United Kingdom
5Institute of Human Development, University of Manchester, Manchester, United Kingdom
6Teesside Genetics Unit, The James Cook University Hospital, Middlesbrough, United Kingdom
7Wessex Clinical Genetics Service, Southampton, United Kingdom
8Liverpool Women’s NHS Trust, Liverpool, United Kingdom
9Genetic Health Service NZ, Christchurch Hospital, Christchurch, New Zealand
10Genetic Health Service NZ, Auckland Hospital, Auckland, New Zealand
11Bristol Genetics Laboratory, North Bristol NHS Trust, Bristol, United Kingdom
12West of Scotland Department of Clinical Genetics, Glasgow, United Kingdom
13Royal Devon and Exeter Hospital, Exeter, United Kingdom
14Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, Ireland
15South West Thames Clinical Genetics Service, St Georges Hospital, London, United Kingdom
16Northern Genetics Service, Newcastle Upon Tyne, United Kingdom
17West Midlands Regional Genetics Service, Birmingham, United Kingdom
18MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom
19Wellcome Trust Sanger Institute, Cambridgeshire, United KingdomManuscript Received: 3 March 2016; Manuscript Accepted: 17 June 2016This is an open access article under the terms of the Creative Commons
Attribution License, which permits use, distribution and reproduction in
any medium, provided the original work is properly cited.
Conflicts of interest: None.
Grant sponsor: Health Innovation Challenge Fund; Grant number:
HICF-1009-003; Grant sponsor: Wellcome Trust and the Department of
Health; Grant sponsor: Wellcome Trust Sanger Institute; Grant number:
WT098051; Grant sponsor: National Institute for Health Research.
Correspondence to:
Karen Low, Clinical Genetics, Level B, St Michaels Hospital, Southwell
Street, Bristol, BS2 8EG, UK.
E-mail: Karen.low1@nhs.net
Article first published online in Wiley Online Library
(wileyonlinelibrary.com): 00 Month 2016
DOI 10.1002/ajmg.a.37842KBG syndrome is characterized by short stature, distinctive
facial features, and developmental/cognitive delay and is caused
bymutations inANKRD11, one of the ankyrin repeat-containing
cofactors. We describe 32 KBG patients aged 2–47 years from 27
families ascertained via two pathways: targeted ANKRD11 se-
quencing (TS) in a group who had a clinical diagnosis of KBG
andwhole exome sequencing (ES) in a second group inwhom the
diagnosis was unknown. Speech delay and learning difficulties
were almost universal and variable behavioral problems fre-
quent. Macrodontia of permanent upper central incisors was
seen in 85%. Other clinical features included short stature,
conductive hearing loss, recurrent middle ear infection, palatal
abnormalities, and feeding difficulties. We recognized a new
feature of awide anterior fontanellewith delayed closure in 22%.
The subtle facial features of KBG syndrome were recognizable
in half the patients. We identified 20 ANKRD11 mutations
(18 novel: all truncating) confirmed by Sanger sequencing in2016 The Authors. American Journal of Medical Genetics Part32 patients. Comparison of the two ascertainment groups dem-
onstrated that facial/other typical features were more subtle inA Published by Wiley Periodicals, Inc. 1
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2 AMERICAN JOURNAL OF MEDICAL GENETICS PART Athe ES group. There were no conclusive phenotype–genotype
correlations. Our findings suggest that mutation ofANKRD11 is
a common Mendelian cause of developmental delay. Affected
patientsmay not show the characteristic KBGphenotype and the
diagnosis is therefore easily missed. We propose updated diag-
nostic criteria/clinical recommendations for KBG syndrome and
suggest that inclusion of ANKRD11 will increase the utility
of gene panels designed to investigate developmental delay.
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INTRODUCTION
KBG syndrome (MIM# 148050) [Herrmann et al., 1975] combines
short-stature, macrodontia of the permanent central upper inci-
sors, distinctive facial features, learning difficulties, and neuro-
behavioral problems [Herrmann et al., 1975; Smithson et al., 2000;
Skjei et al., 2007; Sirmaci et al., 2011; Youngs et al., 2011]. Other
recognized features include seizures, cardiac abnormalities, and
hearing loss [Brancati et al., 2006; Youngs et al., 2011; Ockeloen
et al., 2015].Heterozygousmutations inANKRD11 (ankyrin repeat
domain-containing protein 11) were shown to cause KBG
syndrome [Sirmaci et al., 2011]. Deletions of 16q24 including
ANKRD11were reported to lead to a similar phenotype [Willemsen
et al., 2010; Isrie et al., 2012; Sacharow et al., 2012]. In 2006, the
total number of cases reported worldwide was 45 [Brancati et al.,
2006], but the advent of whole exome sequencing (ES) has
increased recognition, including recent reports of over 25 new
KBG patients [Ockeloen et al., 2015; Walz et al., 2015].
We established single gene analysis of ANKRD11 (TS) as a
diagnostic test at Bristol Genetics Laboratory in 2014 for patients
considered to have KBG syndrome. Concurrently, the Decipher-
ing Developmental Disorders study utilized ES to identify diag-
noses for children with developmental delay and additional
features [Wright et al., 2015]. Here, we describe clinical and
molecular genetic findings in 31 previously unreported KBG
patients and one adult who was previously reported as a child
[Smithson et al., 2000], ascertained through both sources. We
compare the phenotypic characteristics in each of our ascertain-
ment groups and with patients reported by other authors. We
alert clinicians to the key features of KBG syndrome including a
wide fontanelle, which may be the first indication that an infant is
affected. Data on older patients is presented, providing insight
into the long-term outcome of the condition. Recognition of this
diagnosis in young adults has important implications for genetic
counselling.
METHODS
Patients were ascertained either via TS or ES [Wright et al.,
2015] as above. In the TS group, a Clinical Geneticist in the UK
(or New Zealand in one case) had suspected the diagnosis of
KBG syndrome based on clinical features and sent a DNA
sample to Bristol Genetics Laboratory for ANKRD11 analysis.
Consent for genetic testing was obtained at the time ofsample collection. The ES group of children had been recruited
to the DDD study because no clinical diagnosis had been made
(20 patients from 10 of the 23 UK Clinical Genetic Centers).
These children had a history of developmental delay/intellectual
disability with or without additional features. DNA samples
were collected as parent/child trios. Array CGH and ES were
performed looking for copy number variation (CNV) and de
novo variants. Variants were interrogated on the basis of link to
phenotype and using standard in silico tools [Wright et al.,
2015]. A DDD-approved complementary analysis project
(CAP) allowed us to access the exome data and phenotypes
of all subjects identified with ANKRD11 variants through the
DDD Decipher website [Firth et al., 2009]. For both groups,
clinicians responsible for the patients’ care were approached.
Patient consent and phenotyping was initially undertaken by
the referring clinician and reviewed by KL and SS. A deep
phenotyping questionnaire was devised based on current liter-
ature. Broad subheadings in the questionnaire included growth,
development, learning, vision and hearing, neurobehavioral,
skeletal, dental, cardiac, gastrointestinal, immune, and other
features. We paid particular attention to learning difficulties
and behavioral phenotype which are often significant in KBG
syndrome [Lo-Castro et al., 2013].
Genomic DNA was received from an external laboratory or
isolated from peripheral blood leukocytes using a Gentra Puregene
cell kit (QIAGEN Ltd). Coding regions of the ANKRD11 gene (13
exons including intron/exon boundaries extending to the branch
sites) were amplified in 27 fragments using a MegaMix (Micro-
Zone). Primers were designed to GenBank Reference Sequence
NM_013275.5 using Primer3 software [Koressaar and Remm,
2007; Untergasser et al., 2012]. The large size of exon 9 (>6 kb
of coding sequence) required the design of 17 overlapping se-
quencing amplicons in order to cover the whole exon. The high GC
content of the ANKRD11 gene necessitated the use of a GC-RICH
(Roche) PCR system. Primer sequences are available on request.
M13 tagged bidirectional sequencing was undertaken using a
BigDye Terminator v3.1 Cycle Sequencing Kit and 3730 DNA
Genetic Analyzer (Applied Biosystems) with Mutation Surveyor
DNA Variant Analysis Software v3.97 (Softgenetics). Alamut
software v2.3.1 (Interactive Biosoftware, Rouen, France) was
used to predict the effect of genetic variation. The software
integrates PolyPhen-2, Align GVGD and SIFT and five splice
LOW ET AL. 3site prediction programs: SpliceSiteFinder, MaxEntScan, Human
Splice Finder, NNSPLICE, and GeneSplicer. All DDD results
were confirmed by Sanger sequencing either in our laboratory
or locally.
RESULTS
We studied 32 patients from 27 families in total. Thirteen patients
were ascertained through our Bristol laboratory and for 12 (11 from
the UK and one New Zealand) TS was undertaken. One additional
patient had a microdeletion of 16p24.3 including ANKRD11
identified by array CGH but was excluded from the study.
Four patients were from one family (a father and three daughters).
Twenty patients were ascertained through DDD including one
family (a mother, son, and daughter).
All but two patients consented to clinical photographs. In our
analysis of the clinical findings of KBG we initially considered our
cohort separately. We then amalgamated our data with those
previously published which enabled us to estimate the frequency
of features in 100 patients (Fig. 1i and j). The wide age range in our
cohort provided some insight into the developmental outcome and
prognosis in KBG syndrome.Facial Features
The facial features of our patients with KBG syndrome are
shown in Figure 2a and b (ascertained through ES above and
TS below). Subjective appraisal of the images confirmed the
presence of characteristic facial features in some but not all
patients. These included broad triangular face, short neck, wide
or bushy eyebrows, often with synophrys, hypertelorism, prom-
inent ears or dysplastic helices, bulbous nasal tip, prominent
nasal bridge, long and smooth philtrum, and thin upper lip. We
found that patients in the TS group were more likely to express
several of these features. A few patients in the ES group could not
be identified as having KBG syndrome on the basis of their facial
features.Growth
The parameters of growth in our patients (Fig. 1a–c) are in keeping
with the other reported cohorts [Kim et al., 2015; Ockeloen et al.,
2015] and cumulative data showed the frequency of short stature
(height <3rd centile) was 40% (Fig. 1i).Perinatal Period
Few complications occurred in pregnancy and most 20-week
anomaly scans were normal apart from single instances of a single
umbilical artery, an atrio-ventricular septal defect (AVSD),
placenta praevia, and decreased fetal movements. All babies
reached a gestation of at least 36 weeks and the vast majority
were delivered at term. Only two babies were breech presentation.
Birthweightswere allwithinnormalparameters (2nd–98th centiles).
Nineteen percent (6/32) of babies were reported to have significant
feeding difficulties after birth with some requiring nasogastric
tube-feeding (Fig. 1h).Developmental Progress/Learning Difficulties
The ages at which milestones were reached was delayed
(Fig. 1d), especially speech; most patients used their first single
words between 2 and 3 years of age and one patient had only a
few words aged 4. All children achieved walking and the oldest
to do so was aged 3 years and 2 months. In no instances did
patients lose skills or regress. Four patients attended a school
for children with special needs and four went to a mainstream
school but within a specified special needs unit (two within an
autism unit). The rest attended mainstream school usually with
a statement of educational needs and received variable one to
one support within the classroom. Across the literature, 99% of
patients had learning difficulties (Fig. 1i), but they could be
very mild.Neurodevelopment/Behavior
Fourteen patients (43%) had seizures although the age of onset
varied from infancy to mid-teens. Seizure type was heterogeneous
and included absences, grand mal, myoclonic jerks, and nocturnal
seizures. Some patients without a diagnosis of epilepsy had staring
episodes, infantile seizures, or febrile fitswhich resolved. BrainMRI
scans were available in 13 children; 2 showed single abnormalities
including mild periventricular leukomalacia with normal ven-
tricles and an isolated dilated left ventricle. Two scans showed
moderate enlargement of the cisterna magna with normal ven-
tricles (one also showing atrophic changes). Only four children had
a movement disorder including one with Tourette-like tics. One
adult had a wide-based gait with apparent foot drop and involun-
tary flailing of the arms on walking. Eight children (25%) had a
formal diagnosis of autistic spectrumdisorder (ASD) and onemore
had some autistic features. Five patients had a diagnosis of atten-
tion deficit hyperactivity disorder (ADHD) and three others had
mild symptoms in this spectrum.
Behavioral issues occurred in all but two of the patients;
however, their nature was vary variable and in some cases
mild. There were recurring themes, such as poor concentration,
lack of attention span, and restless movement. Some patients had
obsessions and could become fixated on a favorite object or
routine or disliked change with behavior deteriorating at times of
stress. Anxiety and shyness were reported in several patients
associated with difficulty in understanding social situations
and making friendships. In contrast, some parents noted a
lack of stranger-awareness and disinhibition in their children
when interacting with others. Some patients were described as
having a low anger threshold and a few had severely challenging
behavior such as tantrums, inconsolable upset, and occasional
aggressive outbursts. One patient had a diagnosis of oppositional
defiant disorder. Other problems included a sensory processing
disorder, rocking and flicking of elastic bands, a very unusual
phenotype of echolalia-imitation of an American accent, and
autistic-type behavior. Sleep disturbances were reported in six
patients and the majority were resistant to melatonin. Two
further patients had severe sleep disruption as babies which
resolved with age. One child had sleep apnea which persisted
after adenotonsillectomy.
FIG. 1. Clinical features of KBG syndrome. (a–c) Bar charts show number of patients in each centile category for weight, head circumference,
and height. (d) Box and whisker plot indicates age in months at which patients were first able to sit, walk, and speak first words (dots
denote statistical outliers). (e–h) Bar charts demonstrate numbers of patients showing specific oral, skeletal, ocular anomalies, and feeding
difficulties. (i–j) Tables compare the frequency of specified features in patients our cohort compared with cumulative data (ours and
previously reported cases) and the frequency of features in the two ascertainment groups. In e,f, and i the bracketed numbers denotes the
total number of patients in which the feature/data could be sought. (i)Cumulative data from Ockeloen et al. [2015]; Busa et al. [2015]; and
Walz et al. [2015].
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FIG. 2. Facial, dental and limb features in KBG syndrome. (a) Facial features of patients with KBG syndrome during infancy, childhood, and
targeted testing (TS, below). (b) Evolution of the facial phenotype and profile of 3 patients with KBG syndrome during childhood and
adolescence ascertained through TS (2 patients above) and TS (1 patient below). (c) Secondary dentition of patients with KBG showing
macrodontia of central incisors, dental crowding, and extra teeth in some cases. The hands and feet show subtle brachydactyly and
clinodactyly of fifth fingers. [Color figure can be viewed at wileyonlinelibrary.com].
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The key dental findings in our study (Figs. 1e and 2c) included
macrodontia1 of upper incisors in most of our patients (23/27 with
secondary dentition) and 82% of patients with KBG syndrome
overall (Fig. 1i). Palatal abnormalities occurred in a quarter of
patients (8/32); four had sub-mucous cleft palate, two had bifid
uvulas, one had velopharyngeal incompetence and one had a
short palate necessitating two pharyngoplasties. Two further
patients had hyper-nasal speech, but neither was formally assessed
by a palate team nor had a comprehensive examination under
anaesthetic, which was the case for the majority of patients. We
may therefore have underestimated the frequency of palatal
abnormalities.
Permanent conductive hearing loss of varying degrees was
reported in a quarter of patients (8/32), all of whom had a history
of recurrent otitis media and/or tympanic membrane perforation
treated with grommet insertion. A further seven reported recurrent
middle ear infections without lasting hearing loss. One patient
required tympanic membrane grafts at the age of 13 and another
had sensorineural hearing loss in the context of a positive maternal
family history.Skeleton
The most consistent findings were in the distal limbs including
brachydactyly especially of the 5th fingerswith striking clinodactyly
(Fig. 1f). Hand function was normal. The feet were also affected
with brachydactyly; often with wide spaces between the 1st and 2nd
toes. Interestingly seven (22%) of patients had a large anterior
fontanelle with delayed closure; in one patient it still remains patent
aged 4.5 years. Ockeloen et al. [2015] reported the same finding in
patient 6 of their cohort. A further two patients were reported to
have a very large fontanelle as a baby, but this did not persist. A
skeletal survey was available in six patients and three of these
revealed significant but non-specific radiological signs. The first
showed a copper-beaten appearance of the skull with small anterior
beaks on the vertebrae at the thoracolumbar junction. Another
showed radial-head dislocation with a wide carrying angle at the
elbow, short distal phalanges, and a thoracic kyphosis. The third
showed shortening of the pedicles of the lumbar vertebrae, brachy-
cephaly, and a relatively long fibula on the side examined. A fused
metopic suture was reported in one patient.Gastrointestinal System
Gastrointestinal problems were seen in several patients. Feeding
difficulties were the most notable affecting eight patients. These
started in the neonatal period and resolved in some cases (Fig. 1h)
but continued in three cases. One girl, who failed to thrive required
nasogastric feeding until the age of 4 years and her weight remained
below the 0.4th centile at 13 years.One boywas unable to feed orally
at the age of 4.5 years and is dependent on a gastrostomy tube1It is acceptable to assess macrodontia subjectively for apparently increased
maximum width of the tooth; or objectively by measuring mesiodistal tooth
diameter (width)more than 2 SD abovemean for age.[Carey et al., 2009]. In our
cohortmacrodontiawas assessed subjectively by the referring clinician and then
again on review of the images.(he also has a sensory processing disorder and autism). Gastro-
oesophageal reflux and severe constipationwere also observed.One
adult has a life-long history of diarrhea and an abnormal lack of
thirst which has resulted in two hospital admissions for dehydra-
tion. One requires a patch for continual drooling.Other Aspects of Phenotype
Half the patients (17/32) had eye abnormalities, most commonly
strabismus and refractive errors (Fig. 1g). Congenital heart abnor-
malities occurred in 4/32 (13%), including a patent ductus arterio-
sus, anAVSD and twopatients had small VSDs.One further patient
had a structurally normal heart but second degree heart block on
ECG (aged 6).
Many patients displayedmild hypertrichosis with thick hair, full
eyebrows with lateral interruptions and mild synophrys
(Fig. 2a and b). Skin abnormalities were found in several patients.
One had a speckled hyperpigmented patch over his inguinal region.
He also had two hair whorls on left and right sides of the occiput
and a low V-shaped posterior hairline. One patient had a large
hyperpigmented patch on his left arm and another had an asym-
metric hair line, a tendency to skin bruising, and delayed wound
healing. One had keloid scarring with rapid-growing thick hair and
nails. Another had generalised ichthyosis and predominantly lower
limb lymphoedema. Cutismarmoratawas described in one patient.
Dystrophic nails, particularly on the toes, occurred in 6/32 patients.
Recurrent infections (largely respiratory) were described in 6/32
patients although immune function studies did not detect any
specific deficit. Five patients had surgery for cryptorchidism and
one also had an inguinal hernia repair.Adulthood
Eight of the cohort were aged 18 or over including a parent
identified after his daughter was diagnosed. He reported slow
educational progress at primary school and did not achieve qual-
ifications but was living independently as a father of three with no
external help. Similarly, a mother diagnosed after KBG syndrome
was identified in her son through DDD, described mild learning
difficulties but was living independently, working in a kitchen and
looking after her family without support. Her son achieved a few
GCSE-level qualifications and was living in his own accommoda-
tion with some help from social services. The other five young
adults were all living with their parents who considered it was
unlikely they would be able to live alone, although they had many
skills such as being able to operate computers. Twowere embarking
on college courses at the time of the study.Genotype–Phenotype Correlations
Within our cohort, we identified 20 differentANKRD11mutations
in 32 patients with KBG syndrome (Supplementary Table SI). All
mutations reside within exon 9, consistent with it containing
>80%of the coding sequence and are predicted to cause truncation
of the ANKRD11 protein concurring with the mechanism of
pathogenicity previously described [Walz et al., 2015]. Of the 20
mutationswe identified, 18were previously unreported. Previously
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LOW ET AL. 9described mutations were found in eight patients (four from the
same family) with c.1903_1907del [Ockeloen et al., 2015; Parenti
et al., 2016] (Table Ia) and one patient with c.2398_2401del
[Walz et al., 2015]. Novel recurrent mutations identified in this
study included a deletion in three patients, c.2408-2412del and a
nonsense mutation, c.1801C>T, p.(Arg601) in two patients
(Table Ib). The additional novel mutations occurred in single
patients. Comparison of the phenotypes of all reported cases
of recurrent mutations did not highlight specific correlations,
although we noted that none of the eight c.1903_1907del patients
had hearing loss or severe otitis media which was common in the
cohort overall.
In addition to the patients in this study, we have analyzed
additional samples for patients who were referred for TS or for
validation after DDD. In this group an additional six mutations
have been identified, two of which are of interest because they are
outside exon 9. The first, a de novo frameshift in exon 6, occurred
in a patient (DDD266108) with developmental delay, speech
impairment, clinodactyly, anisocoria, and unusual face shape.
The other, a nonsense mutation in exon 4, occurred in a child
and mother with typical features of KBG Syndrome.DISCUSSION
This study of British patients with a molecular genetic diagnosis of
KBG syndrome is the largest to date, bringing the total number of
published cases to>100. Our findings show that the characteristic
facial phenotype of KBG syndrome can be recognized as indicated
in previous reports [Herrmann et al., 1975; Smithson et al., 2000;
Brancati et al., 2006; Skjei et al., 2007; Sirmaci et al., 2011; Youngs
et al., 2011; Ockeloen et al., 2015]. On review of a panel of patient
photographs, (Fig. 2) we identified in some but not all patients a
triangular face, almond-shaped palpebral fissures which may slant
upwards, synophrys, prominent ears, a high nasal bridge and
bulbous nasal tip, prominent cheekbones, a smooth philtrum
with thin upper lip, prominent corners of the mouth, and facial
hypertrichosis/low hairlines. Our impression from available data is
that the features can evolve in childhood and becomemore obvious
in time.We agree with other authors that while some KBG patients
can be recognized by gestalt, others may resemble Cornelia de
Lange syndrome (CDLS). Ansari et al. [2014] found that 3/163
CDLS-like patients had ANKRD11 mutations and Busa et al.
[2015] reported on a French cohort of 20 mutation/deletion cases
and commented that the facial features were reminiscent of CDLS.
Parenti et al. [2016] also found an overlap in phenotyping and
advised ANKRD11 analysis for CDLS mutation negative patients.
In our patients, we observed some facial similarities with CDLS,
particularly the appearance of the eyebrows and eyelashes.
When we compared the facial phenotypes of patients in the two
diagnostic pathways, we observed that in the targeted group the
gestalt was present in a higher proportion of cases than in the DDD
group, where it was only clear in three. In some patients, we
considered that that the specific facial features were not present,
consistent with the high ascertainment from the DDD study (19/32
cases).
In 22% of patients, we found a wide anterior fontanelle with
delayed closure and speculate this may contribute to the triangular
10 AMERICAN JOURNAL OF MEDICAL GENETICS PART Aface shape in KBG syndrome. In some cases this was the presenting
feature and led to consideration of cleidocranial dysostosis (MIM#
119600). Furthermore, delayed closure of the anterior fontanelle
is one of the most distinctive features according to the Decipher
gene browser view for ANKRD11. Other conditions with cranial
involvement and a similarly broad forehead include Robinow
syndrome (MIM # 180700) which was investigated in one patient
in this study. Five of the patients were referred for investigation of
possible craniosynostosis on the basis of the broad forehead and
brachycephaly, but no evidence of fused cranial sutures was found.
Although, patients with KBG syndrome can be relatively short in
stature, we did not find evidence of a generalised skeletal dysplasia.
The most consistent finding was brachydactyly with short tubular
bones in the hands and feet radiographically. One of our patients
(13) has been treated with growth hormone and some success has
been reported elsewhere [Reynaert et al., 2015].
Our study clearly shows a predisposition for recurrent otitis
media in KBG syndrome. This is important to identify and treat to
reduce hearing loss and optimise speech development. We also
identified palatal abnormalities/dysfunction in a quarter of
patients, whichmay bemissed without specialist assessment. Based
on the findings of this study and others, we recommend some key
measures for all patients with a new diagnosis of KBG syndrome
(summarized in Table II) to assist pediatric and other colleagues
involved in the care of patients.
All patients in this study had amutation inANKRD11, amember
of a family of Ankyrin repeat containing cofactors described a
decade ago [Zhang et al., 2004] which is expressed in a wide variety
of tissues including the brain. It is implicated in activation of
transcription by interaction with p160 coactivator and nuclear
receptor complex by recruiting histone deacetylases [SirmaciTABLE II. Recommendations for Clinical Man
Recommended inves
Diagnosis Molecular tes
Array CGH for
Care coordinated by key clinician Hospital or c
Investigations to consider in all patients Echocardiogr
Palatal asses
Hearing and
Specialist de
Referrals and on-going surveillance that may be required Neurology for
Cardiology if
Dietician for
Endocrinology
Surgery for c
Respiratory/s
ENT/audiolog
Management of learning and behaviour Paediatric MD
behaviour
Educational s
Investigations that may be indicated in individual patients Skeletal surv
Renal ultraso
MRI brain scaet al., 2011]. This may account for the pleiotropic effects of
ANKRD11 alterations. Subsequently, Ankrd11 has been shown
to be a crucial chromatin regulator that controls histone acetylation
and gene expression during neural development [Gallagher et al.,
2015]. This provides a likely explanation for the widespread finding
of variable learning difficulties and other cognitive dysfunction in
our cohort. Yoda mice, heterozygous for a missense mutation in
ankrd11 show craniofacial anomalies, wide skulls, kyphoscoliosis,
and reduced bone mineral density, but no other costovertebral
anomalies ormacrodontia [Sirmaci et al., 2011]. The precise role of
ANKRD11 in bone formation and modelling is also currently
unknown.
Like other authors, we did not establish a predictive value for
specific mutations, but it is possible that c.1903_1907del may be
associated with a relatively mild phenotype with respect to ear
infections and hearing loss and further work will be required to
clarify this. This lack of genotype–phenotype correlation suggests
that the variable nature of the KBG syndrome cannot be attributed
to the position of truncation of the protein. This supports a
common mechanism of pathogenicity in which truncating muta-
tions in the C terminal domain would be expected to affect protein
degradation [Walz et al., 2015]. Comparison of the phenotypes in
patients 5–8 and 29–31 demonstrate intra-familial variability and
variable penetrance.
In addition to comparing the facial features, we revisited the
whole phenotype in the two ascertainment groups. If sufficient
characteristics are present, such as macrodontia in a child with
developmental/speech delay, or learning difficulties, it is likely the
diagnosis ofKBG syndromewill be considered andTS initiated. It is
clear from this study that the presentation is variable and the
diagnosis can be missed [Ashraf et al., 2015], especially in infantsagement of Patients With KBG Syndrome
tigations/follow up
ting ANKRD11
16q24 microdeletion if KBG phenotype and ANKRD11 sequencing normal
ommunity paediatrician for children and GP for adults
am
sment with specialist team
vision assessment
ntal review
seizures and movement disorders
heart lesion identified
feeding issues
for investigation of short stature if present
ryptorchidism and hernia
leep studies for apnoea
y for recurrent otitis media and/or hearing loss
T assessment for developmental delay, ASD/ADHD and complex
patterns
upport where required
ey/assessment of bone age
und
n
FIG. 3. Diagnostic aid for KBG syndrome.
LOW ET AL. 11and young children. ForKBG, ESmethodology revealed that a non-
specific ANKRD11-related phenotype exists, as found for other
conditions [Need et al., 2012]. To date (January 2016), in addition
to those reported here, 14 further patients with a variant in
ANKRD11 have been identified by the DDD study (32 intragenic
SNV/indels and one intragenic deletion in the first 4294 trios). This
is consistent with our finding that the gestalt can be unclear and
easily missed.
Skjei et al. [2007] suggested diagnostic criteria for KBG syn-
drome which required at least 4/8 features including delayed bone
age and costovertebral anomalies to be present. Ockeloen et al.
[2015] suggested that only 3/8 may be necessary based on their
Dutch cohort. However, in our experience and in previous reports,
many patients have not had an estimation of bone age or skeletal
survey as they were not clinically indicated. Furthermore, despite
consensus regarding the gestalt of KBG, our data demonstrate that
the facial features can be very subtle or unrecognizable. We have
therefore, devised a diagnostic aid for KBG syndrome (Fig. 3)
which does not rely on the original features-this would have
identified all but one (patient 22 who is notably atypical in his
overgrowth parameters) in our cohort. DDD has detected some
mild cases with few features and colleagues who are experienced in
clinical dysmorphology did not consider KBG syndrome in their
differential diagnosis (personal communications).CONCLUSIONS
This study is the largest to date of patients with KBG syndrome.
Detailed phenotyping has provided data on the range of physical
features in this condition including wide anterior fontanelle with
delayed closure, not previously described. We report on the
significant range of developmental and behavioral problems that
affect patients. The presentation of KBG may be non-specific and
the diagnosis made for the first time through ES; therefore, we
recommend that ANKRD11 is included in gene panels used toinvestigate developmental delay. KBG syndrome is emerging as a
Mendelian cause of learning difficulties with important implica-
tions for genetic counselling given the autosomal dominant
inheritance of this condition. We have devised a revised diagnostic
aid for clinical use and suggest clinical investigations and follow up
that are likely to improve patient care.ACKNOWLEDGMENTS
We thank the patients and families for their helpful participation
in this work and all colleagues who have contributed to the data
presented here. The DDD study presents independent research
commissioned by the Health Innovation Challenge Fund
[grant number HICF-1009-003], a parallel funding partnership
between the Wellcome Trust and the Department of Health, and
the Wellcome Trust Sanger Institute [grant number WT098051].
The views expressed in this publication are those of the author(s)
and not necessarily those of the Wellcome Trust or the Depart-
ment of Health. The study has UK Research Ethics Committee
approval (10/H0305/83, granted by the Cambridge South REC,
and GEN/284/12 granted by the Republic of Ireland REC).
The research team acknowledges the support of the National
Institute for Health Research, through the Comprehensive
Clinical Research Network.REFERENCES
Ansari M, Poke G, Ferry Q, Williamson K, Aldridge R, Meynert AM,
Bengani H, Yee Chan C, Kayserili H, Avci S, Hennekam RCM, Lampe
AK, Redeker E, Homfray T, Ross A, Falkenberg Smeland M, Mansour S,
Parker MJ, Cook JA, Splitt M, Fisher RB, Fryer A, Magee AC, Wilkie A,
Barnicoat A, Brady AF, Cooper NS, Mercer C, Deshpande C, Bennett
CP, Pilz DT, Ruddy D, Cilliers D, Johnson DS, Josifova D, Rosser
E, Thompson EM, Wakeling E, Kinning E, Stewart F, Flinter F, Girisha
KM, Cox H, Firth HV, Kingstn H, Wee JS, Hurst JA, Clayton-Smith J,
12 AMERICAN JOURNAL OF MEDICAL GENETICS PART ATolmie J, Vogt J, Tatton-Brown K, Chandler K, Prescott K, Wilson L,
Behnam M, McEntagart M, Davidson R, Lynch S, Sisodiya S, Mehta
SG,McKee SA,Mohammed S, Holden S, Park S, Holder SE, Harrison V,
McConnell V, Lam WK, Green AJ, Donnai D, Bitner-Glindzicz
M, Donnelly DE, Nellaker C, Taylor MS, Fitzpatrick DR. 2014. Genetic
heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like
phenotypes with observed and predicted levels of mosaicism. J Med
Genet 51:659–668.
Ashraf T, Irving M, Canham N, Holder S, Foulds N, Magee A, McConnell
V, Fisher R, McEntagart M, Tolmie J, Joss S, Clayton-Smith J, Study
DDD. 2015. KBG syndrome: A DDD front-runner? Eur Soc Hum Genet
Abstract PM08 38 159.
Brancati F, Sarkozy A, Dallapiccola B. 2006. KBG syndrome. Orphanet J
Rare Dis 12:1–50.
Busa T, Tessier A, Riccardi F, Jacquette A, Genevieve D, Gatinois V,
Lacombe D, Michaud V, Rossi M, Lebreton C, Leheup B, Vincent-
Delorme C, Delahaye A, Van Maldergem L, Cacciagli P, Scheffer H,
Saugier-Weber P, Goldenburg A, Philip N. 2015. KBG syndrome: A
series of 20 French patients. Eur Soc Hum Genet Abstract PS11 79 223.
Carey JC, Cohen MM, Jr, Curry CJR, Devriendt K, Holmes LB, Verloes A.
2009. Elements of morphology: Standard terminology for the lips,
mouth, and oral region. Am J Med Genet Part A 149A:77–92.
Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van
Vooren S, Moreau Y, Pettett RM, Carter NP. 2009. DECIPHER: Data-
base of chromosomal imbalance and phenotype in humans using
ensembl resources. Am J Hum Genet 84:524–533.
GallagherD, Voronova A, ZanderMA,CancinoGI, Bramall A, KrauseMP,
Abad C, Tekin M, Neilsen PM, Callen DF, Scherer SW, Keller GM,
Kaplan DR, Walz K, Miller FD. 2015. Ankrd11 is a chromatin regulator
involved in autism that is essential for neural development. Dev Cell
32:31–42.
Herrmann J, Pallister PD, TiddyW, Opitz M. 1975. The KBG syndrome-a
syndrome of short stature, characteristic facies, mental retardation,
macrodontia and skeletal anomalies. Birth Defects Orig Artic Ser
11:7–18.
Isrie M, Hendriks Y, Gielissen N, Sistermans EA, Willemsen MH, Peeters
H, Vermeesch JR, Kleefstra T, Van Esch H. 2012. Haploinsufficiency of
ANKRD11 causes mild cognitive impairment, short stature and minor
dysmorphisms. Eur J Hum Genet 20:131–133.
Kim HJ, Cho E, Park JB, Wy I, Kim HJ. 2015. A Korean family with KBG
syndrome identified by ANKRD11 mutation, and phenotypic compari-
son ofANKRD11mutation and 16q24.3microdeletion. Eur JMedGenet
58:86–94.
Koressaar T, RemmM. 2007. Enhancements and modifications of primer
design program Primer 3. Bioinformatics 23:1289–1291.
Lo-Castro A, Brancati F, Digilio MC, Garaci FG, Bollero P, Alfieri P,
Curatolo P. 2013. Neurobehavioral phenotype observed in KBG
syndrome caused by ANKRD11 mutations. Am J Neuropsychiatr Genet
162B:17–23.
Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT,
Meisler MH, Goldstein DB. 2012. Clinical application of exome
sequencing in undiagnosed genetic conditions. JMedGenet 49:353–361.
Ockeloen CW, Willemsen MH, de Munnik S, van Bon BW, de Leeuw
N, Verrips A, Kant SG, Jones EA, Brunner HG, van Loon RL, Smeets
EE, van Haelst MM, van Haaften G, Nordgren A, Malmgren H,
Grigelioniene G, Vermeer S, Louro P, Ramos L, Maal TJ, van Heumen
CC, Yntema HG, Carels CE, Kleefstra T. 2015. Further delineation ofthe KBG syndrome phenotype caused by ANKRD11 aberrations. Eur J
Hum Genet 23:1270.
Parenti I, Gervasini C, Pozojevic J, Graul-Neumann L, Azzollini J,
Braunholz D, Watrin E, Wendt KS, Cereda A, Cittaro D, Gillessen-
Kaesbach G, Lazarevic D, Mariani M, Russo S, Werner R, Krawitz P,
Larizza L, Selicorni A, Kaiser FJ. 2016. Broadening of cohesinopathies:
Exome sequencing identifies mutations in ANKRD11 in two patients
with Cornelia de Lange-overlapping phenotype. Clin Genet 89:74–81.
Reynaert N, Ockeloen CW, S€avendahl L, Beckers D, Devriendt K, Kleefstra
T, Carels CE, Grigelioniene G, Nordgren A, Francois I, de Zegher F,
Casteels K. 2015. Short stature in KBG syndrome: First responses to
growth hormone treatment. Horm Res Paediatr 83:361–364.
Sacharow S, Li D, Fan YS, Tekin M. 2012. Familial 16q24. 3 microdeletion
involving ANKRD11 causes a KBG-like syndrome. Am JMedGenet Part
A 185A:547–552.
Sirmaci A, Spiliopoulos M, Brancati F, Powell E, Duman D, Abrams A,
Bademci G, Agolini E, Guo S, Konuk B, Kavaz A, Blanton S, Digilio MC,
Dallapiccola B, Young J, Zuchner S, Tekin M. 2011. Mutations in
ANKRD11 cause KBG syndrome, characterized by intellectual disability,
skelmalformations, and macrodontia. Am J Hum Genet 89:289–294.
Skjei KL, Martin MM, Slavotinek AM. 2007. KBG syndrome: Report of
twins, neurological characteristics, and delineation of diagnostic criteria.
Am J Med Genet Part A 143A:292–300.
Smithson SF, Thompson EM,McKinnon AG, Smith IS, Winter RM. 2000.
The KBG syndrome. Clin Dysmorphol 9:87–91.
Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M,
Rozen SG. 2012. Primer3-new capabilities and interfaces. Nucleic Acids
Res 40:e115.
Walz K, CohenD,Neilsen PM, Foster J, 2nd, Brancati F, Demir K, Fisher R,
Moffat M, Verbeek NE, Bjorgo K, Lo Castro A, Curatolo P, Novelli G,
Abad C, Lei C, Zhang L, Diaz-Horta O, Young JI, Callen DF, Tekin M.
2015. Characterization of ANKRD11 mutations in humans and mice
related to KBG syndrome. Hum Genet 134:181–190.
Willemsen MH, Fernandez BA, Bacino CA, Gerkes E, de Brouwer AP,
Pfundt R, Sikkema-Raddatz B, Scherer SW, Marshall CR, Potocki L,
van Bokhoven H, Kleefstra T. 2010. Identification of ANKRD11 and
ZNF778 as candidate genes for autism and variable cognitive im-
pairment in the novel 16q24. 3 microdeletion syndrome. Eur J Hum
Genet 18:429–435.
Wright CF, Fitzgerald TW, Jones WD, Clayton S, McRae JF, van Kogelen-
berg M, King DA, Ambridge K, Barrett DM, Bayzetinova T, Bevan AP,
Bragin E, Chatzimichali EA, Gribble S, Jones P, Krishnappa N, Mason
LE, Miller R, Morley KI, Parthiban V, Prigmore E, Rajan D, Sifrim A,
Swaminathan GJ, Tivey AR, Middleton A, Parker M, Carter NP, Barrett
JC, Hurles ME, FitzPatrick DR, Firth HV, study DDD. 2015. Genetic
diagnosis of developmental disorders in the DDD study: A scalable
analysis of genome-wide research data. Lancet 385:1305–1314.
Youngs EL,Hellings JA, ButlerMG. 2011.ANKRD11 deletion in a 17-year-
old male. Clin Dysmorphol 20:170–171.
ZhangA, Yeung PL, Li C-W, Tsai SC, DinhGK,WuX, Li H, Chen JD. 2004.
Identification of a novel family of ankyrin repeats containing cofactors for
p160 nuclear receptor coactivators. J Biol Chem 279:33799–33805.
SUPPORTING INFORMATION
Additional supporting information may be found in the online
version of this article at the publisher’s web-site.
